- Home
- AXSM vs CC Comparison
AXSM vs CC Comparison
Compare AXSM & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- CC
- Stock Information
- Founded
- AXSM 2012
- CC 2014
- Country
- AXSM United States
- CC United States
- Employees
- AXSM N/A
- CC N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- AXSM Health Care
- CC Industrials
- Exchange
- AXSM Nasdaq
- CC Nasdaq
- Market Cap
- AXSM 4.4B
- CC 2.5B
- IPO Year
- AXSM 2015
- CC N/A
- Fundamental
- Price
- AXSM $95.84
- CC $18.70
- Analyst Decision
- AXSM Strong Buy
- CC Buy
- Analyst Count
- AXSM 14
- CC 8
- Target Price
- AXSM $124.57
- CC $26.75
- AVG Volume (30 Days)
- AXSM 405.5K
- CC 1.2M
- Earning Date
- AXSM 11-04-2024
- CC 10-24-2024
- Dividend Yield
- AXSM N/A
- CC 5.33%
- EPS Growth
- AXSM N/A
- CC N/A
- EPS
- AXSM N/A
- CC 0.77
- Revenue
- AXSM $291,489,000.00
- CC $5,735,000,000.00
- Revenue This Year
- AXSM $42.50
- CC N/A
- Revenue Next Year
- AXSM $69.28
- CC $6.31
- P/E Ratio
- AXSM N/A
- CC $24.51
- Revenue Growth
- AXSM 59.73
- CC N/A
- 52 Week Low
- AXSM $55.02
- CC $15.10
- 52 Week High
- AXSM $98.40
- CC $32.70
- Technical
- Relative Strength Index (RSI)
- AXSM 64.19
- CC 49.58
- Support Level
- AXSM $89.24
- CC $16.18
- Resistance Level
- AXSM $96.71
- CC $19.39
- Average True Range (ATR)
- AXSM 3.66
- CC 0.67
- MACD
- AXSM 0.02
- CC 0.26
- Stochastic Oscillator
- AXSM 87.05
- CC 78.35
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CC Chemours Company (The)
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.